Author:
Schwarz E R,Kapur V,Rodriguez J,Rastogi S,Rosanio S
Publisher
Springer Science and Business Media LLC
Reference82 articles.
1. Beavo JA . Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev 1995; 75: 725–748.
2. Reffelmann T, Kloner RA . Therapeutic potential of phosphodiesterase 5 inhibition for cardiovascular disease. Circulation 2003; 108: 239–244.
3. Wallis RM, Corbin JD, Francis SH, Ellis P . Tissue distribution of phosphodiesterase families and the effect of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro. Am J Cardiol 1999; 83: 3C–12C.
4. Senzaki H, Smith CJ, Juang GJ, Isoda T, Mayer SP, Ohler A et al. Cardiac phosphodiesterase 5 (cGMP-specific) modulates adrenergic signaling in vivo, and is down-regulated in heart failure. FASEB J 2001; 15: 1718–1726.
5. Gresser U, Gleiter CH . Erectile dysfunction: comparison of efficacy and side effects of the PDE-5i sildenafil, vardenafil and tadalafil: review of the literature. Eur J Med Res 2002; 7: 435–446.
Cited by
48 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献